BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations

被引:51
作者
Pins, Adrian [1 ,2 ,3 ]
Mihm, Martin C., Jr. [1 ,2 ]
Hoang, Mai P. [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
关键词
BAP1; BRAFV600E; Immunohistochemistry; Nevi; Melanoma; SPITZ TUMORS; GERMLINE MUTATIONS; BRAF MUTATION; MELANOMA; UVEAL; NEVI; PREDISPOSE; DIAGNOSIS; BRCA1;
D O I
10.1016/j.humpath.2014.10.015
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
BAPI (BRCA1-associated protein 1) is a tumor suppressor gene whose mutations have recently been reported to increase susceptibility for the development of uveal melanoma, cutaneous atypical and epithelioid melanocytic lesions, clear cell renal cell carcinoma, and other tumors. Screening for BAPI mutation/loss/inactivation and BRAFV600E mutation can be done by immunohistochemistry. We investigated BAP1 and BRAFV600E expression in 193 sporadic melanocytic lesions (11 dermal nevi, 20 congenital nevi, 40 primary and nondesmoplastic melanomas, 40 desmoplastic melanomas, 23 metastatic melanomas, 17 Spitz nevi, 19 atypical Spitz nevi, 8 atypical Spitz tumors, 14 proliferative nodules arising in congenital nevi, 1 nevus during pregnancy) and 30 melanocytic lesions from 3 patients with family history of uveal melanoma and BAP] germline mutation. Most sporadic melanocytic lesions exhibited positive BAP1 nuclear staining, except for 1 proliferative nodule arising in congenital nevus, 1 desmoplastic, 1 nevoid, and 2 metastatic melanomas. BRAFV600E positivity was demonstrated in 80% of dermal, 5% of congenital, 6% of Spitz, and 5.5% of atypical Spitz nevi; 29% of proliferative nodules arising in congenital nevi; and 24% of primary and nondesmoplastic and 35% of metastatic melanomas. Combined BAP1 loss and BRAFV600E staining was seen in 67% of BAP1 tumor syndrome-associated lesions and in none of the sporadic melanocytic proliferations including Spitz and atypical Spitz nevi and atypical Spitz tumors, with the exception of 1 primary melanoma. The combined BAP1-BRAFV600E+ immunoprofile appears to be a constant feature of BAP1 tumor syndrome associated melanocytic lesions, and the designation of Spitz nevi or variants thereof appears to be inaccurate for this group of lesions. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 24 条
[1]   Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers [J].
Abdel-Rahman, Mohamed H. ;
Pilarski, Robert ;
Cebulla, Colleen M. ;
Massengill, James B. ;
Christopher, Benjamin N. ;
Boru, Getachew ;
Hovland, Peter ;
Davidorf, Frederick H. .
JOURNAL OF MEDICAL GENETICS, 2011, 48 (12) :856-859
[2]   Atypical Spitz nevi/tumors: Lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome [J].
Barnhill, RL ;
Argenyi, ZB ;
From, L ;
Glass, LF ;
Maize, JC ;
Mihm, MC ;
Rabkin, MS ;
Ronan, SG ;
White, WL ;
Piepkorn, M .
HUMAN PATHOLOGY, 1999, 30 (05) :513-520
[3]   Combined BRAFV600E-positive Melanocytic Lesions With Large Epithelioid Cells Lacking BAP1 Expression and Conventional Nevomelanocytes [J].
Busam, Klaus J. ;
Sung, Joanne ;
Wiesner, Thomas ;
von Deimling, Andreas ;
Jungbluth, Achim .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (02) :193-199
[4]   BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs [J].
Carbone, Michele ;
Ferris, Laura Korb ;
Baumann, Francine ;
Napolitano, Andrea ;
Lum, Christopher A. ;
Flores, Erin G. ;
Gaudino, Giovanni ;
Powers, Amy ;
Bryant-Greenwood, Peter ;
Krausz, Thomas ;
Hyjek, Elizabeth ;
Tate, Rachael ;
Friedberg, Joseph ;
Weigel, Tracey ;
Pass, Harvey I. ;
Yang, Haining .
JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
[5]   Clumped perinuclear BAP1 expression is a frequent finding in sporadic epithelioid Spitz tumors [J].
Gammon, Bryan ;
Traczyk, Tom N. ;
Gerami, Pedram .
JOURNAL OF CUTANEOUS PATHOLOGY, 2013, 40 (06) :538-542
[6]   Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas [J].
Harbour, J. William ;
Onken, Michael D. ;
Roberson, Elisha D. O. ;
Duan, Shenghui ;
Cao, Li ;
Worley, Lori A. ;
Council, M. Laurin ;
Matatall, Katie A. ;
Helms, Cynthia ;
Bowcock, Anne M. .
SCIENCE, 2010, 330 (6009) :1410-1413
[7]   BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression [J].
Jensen, DE ;
Proctor, M ;
Marquis, ST ;
Gardner, HP ;
Ha, SI ;
Chodosh, LA ;
Ishov, AM ;
Tommerup, N ;
Vissing, H ;
Sekido, Y ;
Minna, J ;
Borodovsky, A ;
Schultz, DC ;
Wilkinson, KD ;
Maul, GG ;
Barlev, N ;
Berger, SL ;
Prendergast, GC ;
Rauscher, FJ .
ONCOGENE, 1998, 16 (09) :1097-1112
[8]   BAP1, a candidate tumor suppressor protein that interacts with BRCA1 [J].
Jensen, DE ;
Rauscher, FJ .
ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN, 1999, 886 :191-194
[9]   Histopathologic clues for the diagnosis of Wiesner nevus [J].
Llamas-Velasco, Mar ;
Carolina Perez-Gonzalez, Yosmar ;
Requena, Luis ;
Kutzner, Heinz .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (03) :549-554
[10]   Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma [J].
Long, Georgina V. ;
Wilmott, James S. ;
Capper, David ;
Preusser, Matthias ;
Zhang, Yuxiao E. ;
Thompson, John F. ;
Kefford, Richard F. ;
von Deimling, Andreas ;
Scolyer, Richard A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (01) :61-65